Journal of the American College of Cardiology publishes 10-year safety and efficacy data on VIVO ISAR, Translumina's polymer-free drug-eluting stent
Aug 14, 2020
Hechingen [Germany]/New Delhi [India] Aug 14 (ANI/PRNewswire): Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology and minimally invasive surgery, announced that Journal of the American College of Cardiology (JACC), which is amongst the top publications in the world for cardiology with a high impact factor as per Journal Citation Reports, has published ten-year follow-up data on its dual-drug polymer-free Drug Eluting stent (DES) VIVO ISAR last week describing its excellent efficacy and safety profile.